Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study

BACKGROUND: Aspirin use in COPD has been associated with reduced all-cause mortality in meta-regression analysis with few equivocal studies. However, the effect of aspirin on COPD morbidity is unknown. METHODS: Self-reported daily aspirin use was obtained at baseline from SPIROMICS participants with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Chest
Autores principales: Fawzy, Ashraf, Putcha, Nirupama, Aaron, Carrie P., Bowler, Russell P., Comellas, Alejandro P., Cooper, Christopher B., Dransfield, Mark T., Han, MeiLan K., Hoffman, Eric A., Kanner, Richard E., Krishnan, Jerry A., Labaki, Wassim W., Paine, Robert, Paulin, Laura M., Peters, Stephen P., Wise, Robert, Barr, R. Graham, Hansel, Nadia N.
Formato: Artigo
Lenguaje:Inglês
Publicado: American College of Chest Physicians 2019
Materias:
COPD
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6414789/
https://ncbi.nlm.nih.gov/pubmed/30593776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2018.11.028
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares